| Dr Sarah Marie Zalone, DO | |
|
805 Alexa Dr Ste D, Mount Sterling, KY 40353-1000 | |
| (859) 432-8002 | |
| Not Available |
| Full Name | Dr Sarah Marie Zalone |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 12 Years |
| Location | 805 Alexa Dr Ste D, Mount Sterling, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710246194 | NPI | - | NPPES |
| 7100269540 | Medicaid | KY |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gateway Recovery Clinic, Pllc | 9830423326 | 3 |
News Archive
Investigators from Children's Hospital Los Angeles and 37 other Children's Oncology Group hospitals in the U.S. and Canada have determined that sodium thiosulfate prevents cisplatin-induced hearing loss in children and adolescents with cancer.
Crigler-Najjar syndrome affects about one in a million people at birth. Because of a defective gene, these individuals lack an essential enzyme in their liver to eliminate bilirubin, a toxic bile pigment that accumulates in all body tissues causing jaundice and potentially leading to irreversible and lethal neurological damage.
Denmark's largest research project on chemical cocktail effects in food, spearheaded by the National Food Institute, Technical University of Denmark, has just been complet
Alexza Pharmaceuticals, Inc. today announced that it has entered into definitive agreements with a select group of institutional investors to raise approximately $18.0 million in gross proceeds in a registered direct offering through the sale of common stock and warrants. The Company agreed to sell a total of 6,685,183 units, each unit consisting of (i) one share of common stock and (ii) one warrant to purchase 0.5 of a share of common stock, at a purchase price of $2.70 per unit.
› Verified 6 days ago
| Entity Name | Sarah Zalone Do Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780102020 PECOS PAC ID: 1052687415 Enrollment ID: O20171030003292 |
News Archive
Investigators from Children's Hospital Los Angeles and 37 other Children's Oncology Group hospitals in the U.S. and Canada have determined that sodium thiosulfate prevents cisplatin-induced hearing loss in children and adolescents with cancer.
Crigler-Najjar syndrome affects about one in a million people at birth. Because of a defective gene, these individuals lack an essential enzyme in their liver to eliminate bilirubin, a toxic bile pigment that accumulates in all body tissues causing jaundice and potentially leading to irreversible and lethal neurological damage.
Denmark's largest research project on chemical cocktail effects in food, spearheaded by the National Food Institute, Technical University of Denmark, has just been complet
Alexza Pharmaceuticals, Inc. today announced that it has entered into definitive agreements with a select group of institutional investors to raise approximately $18.0 million in gross proceeds in a registered direct offering through the sale of common stock and warrants. The Company agreed to sell a total of 6,685,183 units, each unit consisting of (i) one share of common stock and (ii) one warrant to purchase 0.5 of a share of common stock, at a purchase price of $2.70 per unit.
› Verified 6 days ago
| Entity Name | Gateway Recovery Clinic, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003377011 PECOS PAC ID: 9830423326 Enrollment ID: O20190703001741 |
News Archive
Investigators from Children's Hospital Los Angeles and 37 other Children's Oncology Group hospitals in the U.S. and Canada have determined that sodium thiosulfate prevents cisplatin-induced hearing loss in children and adolescents with cancer.
Crigler-Najjar syndrome affects about one in a million people at birth. Because of a defective gene, these individuals lack an essential enzyme in their liver to eliminate bilirubin, a toxic bile pigment that accumulates in all body tissues causing jaundice and potentially leading to irreversible and lethal neurological damage.
Denmark's largest research project on chemical cocktail effects in food, spearheaded by the National Food Institute, Technical University of Denmark, has just been complet
Alexza Pharmaceuticals, Inc. today announced that it has entered into definitive agreements with a select group of institutional investors to raise approximately $18.0 million in gross proceeds in a registered direct offering through the sale of common stock and warrants. The Company agreed to sell a total of 6,685,183 units, each unit consisting of (i) one share of common stock and (ii) one warrant to purchase 0.5 of a share of common stock, at a purchase price of $2.70 per unit.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sarah Marie Zalone, DO 805 Alexa Dr Ste D, Mount Sterling, KY 40353-1000 Ph: (606) 276-3223 | Dr Sarah Marie Zalone, DO 805 Alexa Dr Ste D, Mount Sterling, KY 40353-1000 Ph: (859) 432-8002 |
News Archive
Investigators from Children's Hospital Los Angeles and 37 other Children's Oncology Group hospitals in the U.S. and Canada have determined that sodium thiosulfate prevents cisplatin-induced hearing loss in children and adolescents with cancer.
Crigler-Najjar syndrome affects about one in a million people at birth. Because of a defective gene, these individuals lack an essential enzyme in their liver to eliminate bilirubin, a toxic bile pigment that accumulates in all body tissues causing jaundice and potentially leading to irreversible and lethal neurological damage.
Denmark's largest research project on chemical cocktail effects in food, spearheaded by the National Food Institute, Technical University of Denmark, has just been complet
Alexza Pharmaceuticals, Inc. today announced that it has entered into definitive agreements with a select group of institutional investors to raise approximately $18.0 million in gross proceeds in a registered direct offering through the sale of common stock and warrants. The Company agreed to sell a total of 6,685,183 units, each unit consisting of (i) one share of common stock and (ii) one warrant to purchase 0.5 of a share of common stock, at a purchase price of $2.70 per unit.
› Verified 6 days ago